Alina Carmen Porojnicu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Alina Carmen Porojnicu has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Johan Moan
5 shared publicationsArne Dahlback
University of Oslo
3 shared publications- Jens Petter Berg
Department of Medical Biochemistry, Institute of Clinical Medicine, University of Oslo, Oslo, Norway
3 shared publications Trude Eid Robsahm
3 shared publications- Oyvind Sverre Bruland
Department of Oncology, Norwegian Radium Hospital, Oslo University Hospital, 0379 Oslo, Norway
2 shared publications - Anne Hansen Ree
Department of Oncology, Akershus University Hospital, Lørenskog, Norway
1 shared publication
Latest Publications
- 1 May 2008
- Published by Elsevier in Journal of Photochemistry and Photobiology B: Biology
- Vol. 91 (2-3) , 125-131
Sun beds and cod liver oil as vitamin D sources
- 1 May 2008
- Published by Elsevier in Journal of Photochemistry and Photobiology B: Biology
- Vol. 91 (2-3) , 125-131
Sun beds and cod liver oil as vitamin D sources
- 31 December 2007
- Published by Springer Nature
- Vol. 624, 43-54
Sun Exposure and Cancer Survival in Norway: Changes in the Risk of Death with Season of Diagnosis and Latitude
Epidemiological and experimental studies suggest that derivatives of vitamin D may improve prognosis of a number of cancer types. Sun is our most important source of vitamin D. Seasonal variations and latitudinal gradients of calcidiol (the marker of vitamin D status) have been reported. We wanted to investigate if season and latitude play any role for survival from seven different cancer types in Norway. Seasonal and geographical variations of vitamin D were estimated by calculations and were compared with clinical data. For the survival analyses, 249373 cancer patients were followed for three years after diagnosis and the risk of death was analyzed separately for summer- and winter diagnosis, as well as for two geographical regions with different UV exposures. We found a 15–25 % better survival for patients diagnosed during summer and a slight beneficial effect for residents of the high UV region for some of the cancer forms investigated. Based on our results we suggest that calcidiol concentration at the time of cancer diagnosis is related to survival and discuss briefly ways to improve the vitamin D levels in the general population.
- 31 December 2007
- Published by Springer Nature
- Vol. 624, 43-54
Sun Exposure and Cancer Survival in Norway: Changes in the Risk of Death with Season of Diagnosis and Latitude
Epidemiological and experimental studies suggest that derivatives of vitamin D may improve prognosis of a number of cancer types. Sun is our most important source of vitamin D. Seasonal variations and latitudinal gradients of calcidiol (the marker of vitamin D status) have been reported. We wanted to investigate if season and latitude play any role for survival from seven different cancer types in Norway. Seasonal and geographical variations of vitamin D were estimated by calculations and were compared with clinical data. For the survival analyses, 249373 cancer patients were followed for three years after diagnosis and the risk of death was analyzed separately for summer- and winter diagnosis, as well as for two geographical regions with different UV exposures. We found a 15–25 % better survival for patients diagnosed during summer and a slight beneficial effect for residents of the high UV region for some of the cancer forms investigated. Based on our results we suggest that calcidiol concentration at the time of cancer diagnosis is related to survival and discuss briefly ways to improve the vitamin D levels in the general population.
- 1 March 2007
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 103 (3-5) , 675-678
Season of diagnosis is a predictor of cancer survival. Sun-induced vitamin D may be involved: A possible role of sun-induced Vitamin D
- 1 March 2007
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 103 (3-5) , 675-678
Season of diagnosis is a predictor of cancer survival. Sun-induced vitamin D may be involved: A possible role of sun-induced Vitamin D
- 1 March 2007
- Published by Elsevier in Lung Cancer
- Vol. 55 (3) , 263-270
Seasonal and geographical variations in lung cancer prognosis in Norway
- 1 March 2007
- Published by Elsevier in Lung Cancer
- Vol. 55 (3) , 263-270
Seasonal and geographical variations in lung cancer prognosis in Norway
- 21 September 2006
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 102 (3) , 323-328
Changes in risk of death from breast cancer with season and latitude
The Norwegian counties can conveniently be divided in three groups with different annual UV exposures and different incidence rates of squamous cell carcinoma (SCC) of the skin. In view of the hypothesis that latitude and season of diagnosis may play a role for breast cancer progression, the prognosis of breast cancer as determined for summer and winter diagnosis, were evaluated in the three residential regions. Two age groups were analysed separately (stratification at 50 years). For all regions, and for all ages, the prognosis was best for women diagnosed in the summer season (Relative risk (RR) of death was 15–25% lower for summer diagnosis versus winter diagnosis). There was no significant seasonal variation of the number of new cases. For women diagnosed before the age of 50, a geographical gradient in cancer prognosis was also found (RR of death 0.6, 95% CI: 0.5–0.7 for cases diagnosed in southeast Norway and RR of death 0.8, 95% CI: 0.6–1.1 for diagnosis in the north of Norway). This is in agreement with a 1.5 times larger annual UV exposures and 3–4 times larger incidence rates of SCC in the southeast region when compared with the north region. For women diagnosed after the age of 50, no significant difference was found between the three regions. Despite a 17% higher vitamin D intake from food in north of Norway no difference in cancer survival was found for diagnosis during winter (when no significant differences in the levels of UV exposure can be detected between regions). The overall data support our earlier hypothesis that season of diagnosis and therapy start improves the survival for breast cancer.
- 21 September 2006
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 102 (3) , 323-328
Changes in risk of death from breast cancer with season and latitude
The Norwegian counties can conveniently be divided in three groups with different annual UV exposures and different incidence rates of squamous cell carcinoma (SCC) of the skin. In view of the hypothesis that latitude and season of diagnosis may play a role for breast cancer progression, the prognosis of breast cancer as determined for summer and winter diagnosis, were evaluated in the three residential regions. Two age groups were analysed separately (stratification at 50 years). For all regions, and for all ages, the prognosis was best for women diagnosed in the summer season (Relative risk (RR) of death was 15–25% lower for summer diagnosis versus winter diagnosis). There was no significant seasonal variation of the number of new cases. For women diagnosed before the age of 50, a geographical gradient in cancer prognosis was also found (RR of death 0.6, 95% CI: 0.5–0.7 for cases diagnosed in southeast Norway and RR of death 0.8, 95% CI: 0.6–1.1 for diagnosis in the north of Norway). This is in agreement with a 1.5 times larger annual UV exposures and 3–4 times larger incidence rates of SCC in the southeast region when compared with the north region. For women diagnosed after the age of 50, no significant difference was found between the three regions. Despite a 17% higher vitamin D intake from food in north of Norway no difference in cancer survival was found for diagnosis during winter (when no significant differences in the levels of UV exposure can be detected between regions). The overall data support our earlier hypothesis that season of diagnosis and therapy start improves the survival for breast cancer.
- Open Access
- 2 August 2005
- Published by Springer Nature in British Journal of Cancer
- Vol. 93 (5) , 571-574
Season of diagnosis is a prognostic factor in Hodgkin's lymphoma: a possible role of sun-induced vitamin D
Experimental studies show that vitamin D derivatives are potent anticarcinogenic factors. Epidemiological observations support this, and vitamin D sufficiency has been hypothesised to be an important risk-reducing factor in several forms of cancer. Vitamin D level exhibits seasonal variations. In the present work, we have investigated the effect of the season of diagnosis on the risk of death among Hodgkin's lymphoma patients diagnosed in Norway between 1964 and 2000. Risk estimates were calculated as relative risk (RR), with 95% confidence intervals (95% CI), using Cox regression model. Epidemiological data for this period indicate that season of diagnosis is a strong prognostic factor for Hodgkin's lymphoma, with approximately 20% lower case fatality for patients diagnosed during autumn vs winter diagnosis (RR = 0.783, 95% CI,-0.62 to 0.99; P = 0.041). Notably, the improved autumnal survival rate was higher than 60% (RR = 0.364, 95% CI, -0.15 to 0.87; P = 0.025) for patients younger than 30 years. This finding may be related to higher endogenous levels of vitamin D in autumn, with a favourable influence on the conventional therapy.
- 2 August 2005
- Published by Springer Nature in British Journal of Cancer
- Vol. 93 (5) , 571-574
Open AccessSeason of diagnosis is a prognostic factor in Hodgkin's lymphoma: a possible role of sun-induced vitamin D
Experimental studies show that vitamin D derivatives are potent anticarcinogenic factors. Epidemiological observations support this, and vitamin D sufficiency has been hypothesised to be an important risk-reducing factor in several forms of cancer. Vitamin D level exhibits seasonal variations. In the present work, we have investigated the effect of the season of diagnosis on the risk of death among Hodgkin's lymphoma patients diagnosed in Norway between 1964 and 2000. Risk estimates were calculated as relative risk (RR), with 95% confidence intervals (95% CI), using Cox regression model. Epidemiological data for this period indicate that season of diagnosis is a strong prognostic factor for Hodgkin's lymphoma, with approximately 20% lower case fatality for patients diagnosed during autumn vs winter diagnosis (RR = 0.783, 95% CI,-0.62 to 0.99; P = 0.041). Notably, the improved autumnal survival rate was higher than 60% (RR = 0.364, 95% CI, -0.15 to 0.87; P = 0.025) for patients younger than 30 years. This finding may be related to higher endogenous levels of vitamin D in autumn, with a favourable influence on the conventional therapy.